Amylyx Pharma Faces Major Setback After Goldman Sachs Downgrade
On March 11, 2024, Amylyx Pharma (NASDAQ: AMLX) received a significant blow as Goldman Sachs analyst Chris Shibutani downgraded the ...
On March 11, 2024, Amylyx Pharma (NASDAQ: AMLX) received a significant blow as Goldman Sachs analyst Chris Shibutani downgraded the ...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.